The Stocking Rule requires a pharmacy “to maintain at all times a 
representative assortment of drugs in order to meet the pharmaceutical needs of 
its patients.” “Representative assortment” is not defined or explained, but it 
plainly connotes a sample, not the physically impossible requirement of 
stocking all drugs approved for human use. And in its forty-year history, the 
Stocking Rule has never been enforced against anybody. When the Pharmacy 
Commission inspects pharmacies, it checks for many things, but not for 
compliance with the Stocking Rule.

Throughout the litigation in the lower courts, there were administrative 
complaints against Stormans pending the with Commission. If and when the 
Commission finally acts on one of those complaints and penalizes Stormans, that 
part of the case will be more ripe. But the intention not to interfere with any 
business reasons for stocking drugs will look no different – it will still 
depend on the drafting history of the regs and the complete lack of enforcement 
action against anyone else.

Douglas Laycock
Robert E. Scott Distinguished Professor of Law
University of Virginia Law School
580 Massie Road
Charlottesville, VA 22903
434-243-8546

From: religionlaw-boun...@lists.ucla.edu 
[mailto:religionlaw-boun...@lists.ucla.edu] On Behalf Of Marty Lederman
Sent: Tuesday, June 28, 2016 12:13 PM
To: Law & Religion issues for Law Academics <religionlaw@lists.ucla.edu>
Subject: Re: Cert. Petition Filed in Pharmacy Free Exercise Case

"[The Ninth Circuit] accepted without question the unwritten ban on religious 
refusals [to stock], and refused to acknowledge the equally unwritten 
permission for business refusals [to stock]."

My understanding is that (i) the stocking rule on its face does not permit any 
reasons for refusal to stock, other than a lack of demand among customers; but 
that (ii) in practice Washington has rarely if ever sanctioned any pharmacy for 
failing to stock any drug--including the plaintiffs here, who have not yet been 
sanctioned.

Therefore the case is woefully premature:  If and when Washington sanctions 
Stormans for refusing to stock Ella or Plan B, and if and when Stormans sues to 
challenge this enforcement action as discriminatory (rather than challenging 
the rules on their face, which are nondiscriminatory, as Stormans did here), 
then we might have a trial to see if the state has declined to likewise 
sanction similarly situated pharmacies that have invoked other sorts of reasons 
for non-stocking, or otherwise treated such pharmacies more favorably than the 
state treats Stormans.

But we're not there yet.

On Tue, Jun 28, 2016 at 11:50 AM, Laycock, H Douglas (hdl5c) 
<hd...@virginia.edu<mailto:hd...@virginia.edu>> wrote:
The lack of clarity in the record arises the state’s decision to pursue its 
goals by indirection. Nothing in the text of the regulations prohibits refusals 
to stock and deliver drugs for religious, moral, or ethical reasons. Yet 
everyone understands that that is the whole point. Nothing in the text of the 
regulations either prohibits or permits refusals to stock and deliver drugs for 
business reasons. Yet nearly everyone understands that permitting the 
longstanding tradition of  refusals for many and varied business reasons was an 
equally intended part of the deal. Everything is clear to the industry, but 
nothing is written down.

The Ninth Circuit allowed this strategy to work. It accepted without question 
the unwritten ban on religious refusals, and refused to acknowledge the equally 
unwritten permission for business refusals.

The argument that it was also part of the intention to prohibit refusals for 
secular ethical reasons is like Hialeah’s argument that its ordinances would 
also apply to voodoo, and that voodoo was not a religion. One tiny application 
that is arguably secular – really just a variation on the religious objection – 
does not make a law generally applicable. And in fact, despite considerable 
effort at trial, the state could find no example of a pharmacist with secular 
moral objections to religious contraception. That appears to be an empty set in 
Washington.

The Alito dissent is apparently why the case was held so long and relisted so 
many times. And of course I like the Alito dissent. But I have to say that his 
footnote 6 is utterly shameless in light of his dissent yesterday in Woman’s 
Whole Health.  He says that of course Stormans can bring “a future as-applied 
challenge to the Board’s regulations.” But yesterday, a much less thorough 
litigation of a pre-enforcement challenge was obviously res judicata in a 
post-enforcement challenge based on actual experience. It is hard to see how he 
can have it both ways.

Douglas Laycock
Robert E. Scott Distinguished Professor of Law
University of Virginia Law School
580 Massie Road
Charlottesville, VA 22903
434-243-8546<tel:434-243-8546>

_______________________________________________
To post, send message to Religionlaw@lists.ucla.edu
To subscribe, unsubscribe, change options, or get password, see 
http://lists.ucla.edu/cgi-bin/mailman/listinfo/religionlaw

Please note that messages sent to this large list cannot be viewed as private.  
Anyone can subscribe to the list and read messages that are posted; people can 
read the Web archives; and list members can (rightly or wrongly) forward the 
messages to others.

Reply via email to